Close Menu

NEW YORK (360Dx) – Researchers at the University of South Florida (USF) are developing a mobile point-of-care version of a laboratory-based enzyme linked immunosorbent assay (ELISA) that potentially could broaden the type of testing that can be done in a doctor's office.

The testing platform could eventually open access in doctors' offices to a range of testing that can only be done currently by sending samples to labs and awaiting their return, Anna Pyayt, one of the test's developers and an assistant professor at the University of South Florida, said in an interview.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.